Literature DB >> 19126367

Methadone: a new old drug with promises and pitfalls.

Jodie A Trafton1, Abhinav Ramani.   

Abstract

Although methadone is not a new medication, its use in pain management has increased rapidly over the past decade. This article reviews the unique pharmacologic properties of methadone, including its long-acting nature, highly variable clearance rate, and its antagonism of the N-methyl-D-aspartate receptor. We discuss potential benefits and risks of methadone over other opioid medications. Preclinical studies suggest methadone may reduce abuse potential, tolerance development, and sensitization of nociceptive pathways. Pharmacologic properties of methadone suggest potential greater risk of dangerous or fatal side effects from overdose, QT interval prolongation, and drug interactions. However, clinical studies have yet to confirm that methadone produces either better clinical outcomes or higher rates of adverse events than other opioid analgesics. Clinicians who understand the special properties of methadone and follow recommended precautionary prescribing and monitoring practices can safely and effectively use methadone for pain treatment.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19126367     DOI: 10.1007/s11916-009-0006-0

Source DB:  PubMed          Journal:  Curr Pain Headache Rep        ISSN: 1534-3081


  43 in total

Review 1.  The role of N-methyl-D-aspartate (NMDA) receptors in pain and morphine tolerance.

Authors:  C E Inturrisi
Journal:  Minerva Anestesiol       Date:  2005 Jul-Aug       Impact factor: 3.051

2.  The d- and l-isomers of methadone bind to the non-competitive site on the N-methyl-D-aspartate (NMDA) receptor in rat forebrain and spinal cord.

Authors:  A L Gorman; K J Elliott; C E Inturrisi
Journal:  Neurosci Lett       Date:  1997-02-14       Impact factor: 3.046

3.  Effect of opioid dependence pharmacotherapies on zidovudine disposition.

Authors:  E F McCance-Katz; P M Rainey; G Friedland; T R Kosten; P Jatlow
Journal:  Am J Addict       Date:  2001

4.  d-Methadone is antinociceptive in the rat formalin test.

Authors:  N Shimoyama; M Shimoyama; K J Elliott; C E Inturrisi
Journal:  J Pharmacol Exp Ther       Date:  1997-11       Impact factor: 4.030

5.  Concomitant drugs of misuse and drug using behaviours associated with fatal opiate-related poisonings in Sheffield, UK, 1997-2000.

Authors:  Phillip Oliver; Jenny Keen
Journal:  Addiction       Date:  2003-02       Impact factor: 6.526

Review 6.  A systematic review of opioid conversion ratios used with methadone for the treatment of pain.

Authors:  Douglas J Weschules; Kevin T Bain
Journal:  Pain Med       Date:  2008-06-28       Impact factor: 3.750

Review 7.  The role of mu opioid receptor desensitization and endocytosis in morphine tolerance and dependence.

Authors:  Lene Martini; Jennifer L Whistler
Journal:  Curr Opin Neurobiol       Date:  2007-12-18       Impact factor: 6.627

8.  The mu1, mu2, delta, kappa opioid receptor binding profiles of methadone stereoisomers and morphine.

Authors:  K Kristensen; C B Christensen; L L Christrup
Journal:  Life Sci       Date:  1995       Impact factor: 5.037

Review 9.  Relationships among morphine metabolism, pain and side effects during long-term treatment: an update.

Authors:  Gertrud Andersen; Lona Christrup; Per Sjøgren
Journal:  J Pain Symptom Manage       Date:  2003-01       Impact factor: 3.612

10.  A review of methadone deaths in Jefferson County, Alabama.

Authors:  Irina Mikolaenko; C Andrew Robinson; Gregory G Davis
Journal:  Am J Forensic Med Pathol       Date:  2002-09       Impact factor: 0.921

View more
  8 in total

1.  [The role of opioids in the treatment of primary headache disorders].

Authors:  A Totzeck; C Gaul
Journal:  Schmerz       Date:  2014-04       Impact factor: 1.107

Review 2.  Methadone for neuropathic pain in adults.

Authors:  Ewan D McNicol; McKenzie C Ferguson; Roman Schumann
Journal:  Cochrane Database Syst Rev       Date:  2017-05-17

3.  Effects of Dextromethorphan on reducing methadone dosage in opium addicts undergoing methadone maintenance therapy: A double blind randomized clinical trial.

Authors:  Mehrdad Salehi; Ali Zargar; Mohammad Arash Ramezani
Journal:  J Res Med Sci       Date:  2011-10       Impact factor: 1.852

4.  Opioid tolerance in methadone maintenance treatment: comparison of methadone and levomethadone in long-term treatment.

Authors:  Stefan Gutwinski; Nikola Schoofs; Heiner Stuke; Thomas G Riemer; Corinde E Wiers; Felix Bermpohl
Journal:  Harm Reduct J       Date:  2016-02-16

Review 5.  Nephrotoxicity of methadone: a systematic review.

Authors:  Samira Alinejad; Kazem Ghaemi; Mohammad Abdollahi; Omid Mehrpour
Journal:  Springerplus       Date:  2016-12-09

6.  Pain, opioid therapy, and survival: a needed discussion.

Authors:  Diane M Novy; David V Nelson; Dhanalakshmi Koyyalagunta; Juan P Cata; Pankaj Gupta; Kalpna Gupta
Journal:  Pain       Date:  2020-03       Impact factor: 6.961

7.  Methadone induction in primary care (ANRS-Methaville): a phase III randomized intervention trial.

Authors:  Perrine Roux; Laurent Michel; Julien Cohen; Marion Mora; Alain Morel; Jean-Francois Aubertin; Jean-Claude Desenclos; Bruno Spire; Patrizia M Carrieri
Journal:  BMC Public Health       Date:  2012-06-28       Impact factor: 3.295

8.  Pain relief after cesarean section: Oral methadone vs. intramuscular pethidine.

Authors:  Azar Danesh Shahraki; Mitra Jabalameli; Somayeh Ghaedi
Journal:  J Res Med Sci       Date:  2012-02       Impact factor: 1.852

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.